Get the content you want anytime you want.

The Contagion® Healthcare Associated Infections (HAI) specialty page provides HAI-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


Study Finds Mattress Covers Cut Hospital CDI Rates in Half
Edmond Hooker, MD, DrPH, discusses a study that assessed the use of mattress covers in hospitals to cut down on CDI rates.
Fidaxomicin in the Treatment of <i>Clostridium difficile</i> Infections
Erik Dubberke, MD; Yoav Golan, MD, MS; and Peter L. Salgo, MD, compare the use of fidaxomicin against standard therapy options, such as vancomycin, for the treatment of Clostridium difficile, suggesting that fidaxomicin may reduce a patient’s risk of recurrence.
How Does Ridinilazole Affect the Gut Microbiome?
Dr. Richard Vickers, explains how ridinilazole affected the gut microbiome in participants of a phase 2 study.
Factors That Impact <i>C. difficile</i> Infection Recurrence
Following a discussion on how to monitor patients with Clostridium difficile for a response to treatment, Lawrence J. Brandt, MD; Erik Dubberke, MD; Dale N. Gerding, MD; Yoav Golan, MD, MS; and Peter L. Salgo, MD, remark on the risk of recurrence and management of patients’ post therapy and how to proceed if recurrence occurs.
Contaminated Hospital Mattresses Act as Vector for Drug-Resistant Infections
Edmond Hooker, MD, DrPH, discusses how contaminated hospital mattresses act as a vector for spreading drug-resistant infections.
Ridinilazole Shows Superior Efficacy for Treatment of <i>C. diff</i> in Phase 2 Study
Dr. Richard Vickers, discusses how ridinilazole showed superior efficacy for the treatment of C. diff when compared with vancomycin in a phase 2 study.
Preparing to Ensure Effective Stock & Delivery of Future <i>C. diff</i> Vaccine
Richard Haupt, MD, MPH, discusses what is needed to ensure that a future C. diff vaccine is adequately stocked and delivered to wherever individuals show up for vaccination.
<i>Pseudomonas</i> Infections: Mortality & Health Care Costs
Marin H. Kollef, MD, discusses the mortality and health care costs associated with Pseudomonas infections.
Influenza A (H3N2) has caused most of the illnesses in this severe flu season, but influenza B is becoming increasingly responsible for more infections as the flu season continues to hit the United States.